Advertisement: Killer 50 TTP Group
30 July, 2014 - 12:43 By News Desk


Abzena provides proprietary technologies and complementary services to organisations involved in the development of biopharmaceutical products.

Working with companies and academic groups all over the world, including most of the top 20 biopharmaceutical businesses, Abzena supports the development and manufacture of better treatments for patients. 

Twelve antibodies which have been created using Abzena’s technologies are currently being progressed through clinical development.


Newsletter Subscription

Stay informed of the latest news and features